Tokyo, Oct. 23 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063289) titled 'Exploratory Study of a Healthcare Indicator Based on a Simple Fecal Short-Chain Fatty Acid Test' on Oct. 22.

Study Type: Observational

Primary Sponsor: Institute - Metagen,Inc.

Condition: Condition - Healthy adults Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - We aim to conduct an integrated analysis of fecal short-chain fatty acid levels, stool characteristics, and various other non-invasively obtainable data to elucidate their associations with abdominal symptoms and blood-based health-related biomarkers. Based on the findings, we will also seek to develop novel healthcare indicators that combine information on short-chain fatty acid levels with other non-invasively obtainable data. Basic objectives2 - Others

Eligibility: Age-lower limit - 20 years-old <= Age-upper limit - Not applicable Gender - Male and Female Key inclusion criteria - (1) Male and female participants aged 20 years or older at the time of informed consent. (2) Individuals who are able to collect stool samples and perform finger-prick blood sampling at home and submit the samples according to the specified procedures. (3) Individuals who have received a sufficient explanation of the study, are able to understand its contents, and can provide informed consent voluntarily. Key exclusion criteria - 1 Individuals who have or are suspected of having an infectious disease that may be transmitted through stool or blood. 2 Individuals who have taken medications that may affect the study results (e.g., antibiotics, probiotics, or laxatives) within one month prior to stool sample collection. 3 Individuals who have undergone surgical procedures that may affect the study results (e.g., endoscopic colorectal surgery, gallstone removal, cholecystectomy, or gastric bypass surgery) within six months prior to obtaining informed consent. 4 Individuals with a current or past history of liver cancer, ulcerative colitis, Crohn's disease, or Parkinson's disease. 5 Individuals who are otherwise deemed ineligible for participation in the study by the principal investigator. Target Size - 100

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 10 Month 22 Day Anticipated trial start date - 2026 Year 10 Month 22 Day Last follow-up date - 2030 Year 03 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072442

Disclaimer: Curated by HT Syndication.